The Influence of Preadipocyte Differentiation Capacity on Lipolysis in Human Mature Adipocytes

Abstract

The ability of catecholamines to maximally stimulate adipocyte lipolysis (lipolytic capacity) is decreased in obesity. It is not known whether the lipolytic capacity is determined by the ability of adipocytes to differentiate. The aim of the study was to investigate if lipolytic capacity is related to preadipocyte differentiation and if the latter can predict lipolysis in mature adipocytes. In vitro experiments were performed on differentiating preadipocytes and isolated mature adipocytes from human subcutaneous adipose tissue. In preadipocytes, noradrenaline-induced lipolysis increased significantly until terminal differentiation (day 12). However, changes in the expression of genes involved in lipolysis (hormone sensitive lipase, adipocyte triglyceride lipase, the α2-and β1-adrenoceptors, perilipin, and fatty acid binding protein) reached a plateau much earlier during differentiation (day 8). A significant positive correlation between lipolysis in differentiated preadipocytes and mature adipocytes was observed for noradrenaline (r=0.5, p<0.01). The late differentiation capacity of preadipocytes measured as glycerol-3-phosphate dehydrogenase activity was positively correlated with noradrenaline-induced lipolysis in preadipocytes (r=0.51, p<0.005) and mature fat cells (r=0.35, p<0.05). In conclusion, intrinsic properties related to terminal differentiation determine the ability of catecholamines to maximally stimulate lipolysis in fat cells. The inability to undergo full differentiation might in part explain the low lipolytic capacity of fat cells among the obese.

β-adrenoceptors - lipolysis - differentiation capacity - noradrenaline - obesity

References

• 1 Lafontan M, Berlan M. Fat cell adrenergic receptors and the control of white and brown fat cell function.  J Lipid Res. 1993;  34 1057-1091
• 2 Jensen MD, Haymond MW, Rizza Ra, Cryer PE, Miles JM. Influence of body fat distribution on free fatty acid metabolism in obesity.  J Clin Invest. 1989;  83 1168-1173
• 3 Mauriege P, Despres JP, Prud’homme D, Lacaille M, Almeras N, Tremblay A, Despres JP. Regional variation in adipose tissue lipolysis in lean and obese men.  J Lipid Res. 1991;  32 1625-1633
• 4 Bougneres P, Stunff CL, Pecqueur C, Pinglier E, Adnot P, Ricquier D. In vivo resistance of lipolysis to epinephrine. A new feature of childhood onset obesity.  J Clin Invest. 1997;  99 2568-2573
• 5 Hellstrom L, Langin D, Reynisdottir S, Dauzats M, Arner P. Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives.  Diabetologia. 1996;  39 921-928
• 6 Reynisdottir S, Wahrenberg H, Carlstrom K, Rossner S, Arner P. Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-adrenoceptors.  Diabetologia. 1994;  37 428-435
• 7 Large V, Reynisdottir S, Langin D, Fredby K, Klannemark M, Holm C, Arner P. Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects.  J Lipid Res. 1999;  40 2059-2066
• 8 Langin D, Dicker A, Tavernier G, Hoffstedt J, Mairal A, Ryden M, Arner E, Sicard A, Jenkins CM, Viguerie N, van Harmelen V, Gross RW, Holm C, Arner P. Adipocyte lipases and defect of lipolysis in human obesity.  Diabetes. 2005;  54 3190-3197
• 9 van Harmelen V, Skurk T, Rohrig K, Lee YM, Halbleib M, Aprath-Husmann I, Hauner H. Effect of BMI and age on adipose tissue cellularity and differentiation capacity in women.  Int J Obes Relat Metab Disord. 2003;  27 889-895
• 10 Kolaczynski JW, Morales LM, Moore Jr JH, Considine RV, Pietrzkowski Z, Noto PF, Colberg J, Caro JF. A new technique for biopsy of human abdominal fat under local anaesthesia with Lidocaine.  Int J Obes Relat Metab Disord. 1994;  18 161-166
• 11 Van Harmelen V, Dicker A, Rydén M, Hauner H, Lönnqvist F, Näslund E, Arner P. Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes.  Diabetes. 2002;  51 2029-2036
• 12 Hellmer J, Arner P, Lundin A. Automatic luminometric kinetic assay of glycerol for lipolysis studies.  Anal Biochem. 1989;  177 132-137
• 13 van Harmelen V, Skurk T, Hauner H. Primary culture and differentiation of human adipocyte precursor cells.  Methods Mol Med. 2005;  107 125-135
• 14 Lofgren P, Hoffstedt J, Naslund E, Wiren M, Arner P. Prospective and controlled studies of the actions of insulin and catecholamine in fat cells of obese women following weight reduction.  Diabetologia. 2005;  48 2334-2342
• 15 Ukropcova B, McNeil M, Sereda O, de Jonge L, Xie H, Bray GA, Smith SR. Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor.  J Clin Invest. 2005;  115 1934-1941
• 16 Sengenes C, Bouloumie A, Hauner H, Berlan M, Busse R, Lafontan M, Galitzky J. Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes.  J Biol Chem. 2003;  278 48617-48626
• 17 Marcus C, Bolme P, Karpe B, Bronnegard M, Sellden H, Arner P. Expression of beta 1- and beta 2-receptor genes and correlation to lipolysis in human adipose tissue during childhood.  J Clin Endocrinol Metab. 1993;  76 879-884
• 18 Knittle JL, Timmers K, Ginsberg-Fellner F, Brown RE, Katz DP. The growth of adipose tissue in children and adolescents. Cross-sectional and longitudinal studies of adipose cell number and size.  J Clin Invest. 1979;  63 239-246

Correspondence